可药性
前药
药品
药理学
癌症治疗
药物发现
抗癌药
化疗
癌症
癌症化疗
娴熟的
癌症研究
组合化学
医学
小分子
化学
纳米技术
材料科学
生物化学
内科学
基因
作者
Peng Wang,Xiaoyue Jin,Jin Cai,Junqing Chen,Min Ji
出处
期刊:Anti-cancer Agents in Medicinal Chemistry
[Bentham Science]
日期:2014-02-01
卷期号:14 (3): 418-439
被引量:9
标识
DOI:10.2174/18715206113139990317
摘要
Chemotherapy has been performed to treat metastatic cancers but with varying degrees of success. The optimal potential of chemotherapy has not been achieved yet. Numerous compounds cannot be further developed to produce potent drugs because these compounds exhibit poor druggability. To resolve this issue, researchers developed prodrugs in drug discovery because these drugs can be efficiently used. Many small-molecule prodrugs have been designed and synthesized as anticancer agents for several years, and great progress has been achieved. In this study, recently developed, efficient anticancer prodrugs were reviewed, particularly small molecule prodrugs. Moreover, small molecule anticancer prodrugs were summarized according to different types of chemical structures and properties. Keywords: Anticancer, cancer, prodrug, small molecule, therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI